Fundraising Fox

PhaseBio Pharmaceuticals

Malvern, US · Delaware corporation · 2 known investors

phasebio.com ↗

PhaseBio is a company focused on developing treatments for cardiovascular disease, which is a leading cause of death in the United States.

BiotechHealthtechMedical Devices

Founders & leadership

JS
Joel SussmanExecutive Officer
JB
James BarrettDirector
MG
Michael GutchDirector
JK
Justin KleinDirector
JM
Jonathan MowExecutive Officer, Director
AK
Asish K. XavierDirector
CT
Clay ThorpDirector
GF
Guy FishDirector
AC
Ashutosh ChilkotiDirector
RI
Robert IngramDirector

Investors · 2

Mountain Group CapitalNashville
Hatteras Venture Partnersreported · 2 sourcesResearch Triangle · $500K – $4Mvia Clay Thorp · board

Reported raises · per SEC filings

Form D private placements
▶$26MraisedSep 2018 · 20 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan MowExecutive Officer, Director
  • Linda TuftsDirector
  • Justin KleinDirector
  • Clay ThorpDirector
  • Bibhash MukhopadhyayDirector
  • John SharpExecutive Officer
  • Nancy HutsonDirector
  • Caroline LoewyDirector
  • Tyrell RiversDirector
Offering amount
$32.1M
Amount sold
$26M
First sale
Aug 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.6MraisedJan 2017 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael GutchDirector
  • James BarrettDirector
  • Jonathan MowExecutive Officer, Director
  • Justin KleinDirector
  • Ashutosh ChilkotiDirector
  • Guy FishDirector
  • Clay ThorpDirector
  • Asish K. XavierDirector
  • Robert IngramDirector
  • John SharpExecutive Officer
Offering amount
$7.9M
Amount sold
$6.6M
First sale
Jan 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21MraisedJul 2015 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joel SussmanExecutive Officer
  • James BarrettDirector
  • Michael GutchDirector
  • Justin KleinDirector
  • Jonathan MowExecutive Officer, Director
  • Asish K. XavierDirector
  • Clay ThorpDirector
  • Guy FishDirector
  • Ashutosh ChilkotiDirector
  • Robert IngramDirector
Offering amount
$42M
Amount sold
$21M
Proceeds to insiders
$900K
First sale
Feb 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.